CLINICAL EVALUATION OF SULBACTAM/CEFOPERAZONE IN COMPLICATED URINARY TRACT INFECTIONS
スポンサーリンク
概要
- 論文の詳細を見る
Fourty-four patients with chronic complicated urinary tract infections were treated with Sulbactam/Cefoperazone at the daily dose of 2g or 4g by intravenous one-shot injection or intravenous drip infusion for 5 days and following results were obtained.<BR>Clinical results were excellent in 11 (25%), moderate in 19 (43.2%) and poor in 14 (31.8%). The effective rate was 68.2%. In overall clinical efficacy of Sulbactam/Cefoperazone classified by type of infection, mono microbial infection was 75.0% and polymicrobial infection was 64.3%.<BR>On bacteriological evaluation, there was eradication of strains in 67 (81.7%), persistence in 15 (18.3%) out of 82 strains. No side-effects were observed in these cases.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.